Login / Signup

Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: rationale and design of SHIFT-AHF trial.

Yang SuTeng MaZeyu WangBin DongChenhui TaiHao WangFenglei ZhangChunxi YanWei ChenYawei XuLei YeGee Jun TyeSang-Bing OngJian ZhangDachun Xu
Published in: ESC heart failure (2020)
The SHIFT-AHF trial will shed further light on the role of early HR reduction using ivabradine in patients with AHF.
Keyphrases
  • acute heart failure
  • phase iii
  • study protocol
  • heart rate
  • phase ii
  • clinical trial
  • heart failure
  • open label
  • atrial fibrillation
  • smoking cessation